Skip to main content
. 2016 Oct 21;17:442. doi: 10.1186/s12891-016-1289-z

Table 3.

IMAB domains and corresponding facilitators and barriers categorized according to COM-B components

COM-B Domain Facilitators Barriers
Capability Knowledge Knowledge of treatment effect
Information about necessity
Information about alternative medication
Information about experiences from others
Knowledge of how to administer medication
Knowledge of side effects
Knowledge of cost of medication
Skills Cognitive abilities
Coping strategies
Communication skills
Fine motor skills
Insufficient cognitive, communicative, or physical skills to understand and/or administer medication
Memory and Attention Treatment effect
Aids (to remember)
Social support
Embedded in daily routine
Lack of daily routine
Experiencing side effects
Forgetting to take medication
Change of appearance of medication
Impact on lifestyle
Lack of treatment effect
Decision-making process Self-management (patient decides)
Satisfying relationship with health professional (communication and trust)
Lack of involvement of health professional (health professional decides, no shared decision making)
Doubting own knowledge
Influence of health insurance companies
Opportunity Environmental context and resources Logistics (having medication in stock)
Access to health professionals
Quality of product (needle)
Logistics (medication storage temperature, pharmacy has no stock)
Cost of medication
Travelling (clearing injectable medications through customs)
Change of name or appearance of medication
Social influences Health professionals (rheumatologist, pharmacist, nurse, general practitioner): capabilities, trust, and empathy
Health insurance company: reimburses medication, provides clear information
Family and friends: support adherence, support in choices of medication, instrumental support
Colleagues: support, understanding
Lack of support from colleagues (incomprehension, negative reactions)
Motivation Beliefs about capabilities Aids (to use, to remember)
Self-efficacy
Good (overall) health status
Difficulty in adherence because of social and work events
Lack of daily routine
Worse health status
Difficult to inject
Experience of side effects
Doubting own knowledge with regard to medication (as barrier to adherence)
Beliefs about consequences Belief of treatment effect
Belief of being able to better participate (social, work)
Experience of (long- and short-term) side effects
Belief that medication will be harmful: higher disease activity
Lack of belief in efficacy
Dependency on medication
Less acceptance of (long-term) medication
Non-acceptance of diagnosis
Emotions Joy
Gratitude
Hope
Confidence
Anxiety
Sadness
Anger
Dependency on medication
Irritation
Incomprehension
Disparity
Powerlessness/helplessness
Insecurity
Feeling overwhelmed
Feeling crestfallen
Grief
Embarrassment
Regret
Stress
Disappointment
Desolation
Despair
Agitation
Motivation and Goals Improvement of Quality of Life
Treatment effect
Social participation (including work)
Improvement of life expectancy
Better relationship with health professional
Maintain autonomy
Worse health status/wellbeing
Side effects
Comorbidity
Complexity of regimen
Resistance of need for medication
Denial of existence of illness
Difficulty administering medication
Lack of daily routine
Goal conflict Embedded in daily routine
Treatment effect leading to active social participation (e.g., work)
Instrumental support (aids, information)
Social support
Method of administration (intravenous or low frequency)
Stock (always available)
Experiencing side effects
Restrictions due to using medication (no alcohol)
Worse well-being (mentally and/or physically)
Not able to participate (social, work)
Distracted from taking medication
Lack of social support